🤖 AI Surgery Black Box

Plus: ChatGPT-powered mental health chatbots, Are GLP-1 agonists safe? FDA finds no evidence

Kaushee Ganeshan
January 16, 2024

Welcome. Here is your briefing:

AI ROUNDUP: ChatGPT-powered mental health chatbots range from mindful to disconcertingly wacko?
INDUSTRY ROUNDUP: Mammography AI can be costly to patients. Is it worth it?
INTERESTING READS: Genetic map makers: Study identifies genes involved in healthy aging
AI TRIVIA: What groundbreaking achievement did Google's DeepMind AI, AlphaFold, accomplish in the field of biology?

Mass General Brigham tests AI surgery blackbox (Read More)
Is Google's healthcare AI more empathetic than physicians? (Read More)
ChatGPT-powered mental health chatbots range from mindfully serious to disconcertingly wacko (Read More)
What to watch in health care in 2024: Obesity drugs, AI (Read More)
CES 2024: Mark Cuban, Glen Tullman sound off on building new models of care for consumers and AI's impact (Read More)
Doctors turn to AI and wearable monitors to measure the effects of burn pits on veterans' health (Read More)
AI to help with pre-diabetes treatment as 1,000 diagnosed in UAE within 100 days (Read More)

Mammography AI can cost patients extra. Is it worth it? (Read More)
Are GLP-1 agonists safe? FDA finds no evidence (Read More)
Marijuana reclassification proposed over lower public health risk (Read More)
Cancer mortality rates decline, health disparities persist (Read More)
Tripledemic may have peaked around the holidays (Read More)

Record budget for Gates Foundation as wider global health funding stalls (Read More)
Genetic map makers: Study identifies genes involved in healthy aging (Read More)
GE HealthCare, breakthroughs the trends reshaping Healthcare (Read More)

FEBRUARY

That’s all for today, follow me on Linkedin. Support us by sharing our newsletter with your colleagues.

Until next time,

Kaushee